Henry E. Pelish, Chief Scientific Officer at Nuvalent, Inc. (NUVL), sold 11,000 shares at $74.85 ($823K) on 2025-08-07, disclosed to the SEC on 2025-08-08.
Scheduled sale ($823k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.85 | 5,500 | $412K | 50.0% |
| 2 | $74.85 | 5,500 | $412K | 50.0% |
| Total | $74.85 avg | 11,000 | $823K | 100% |
| Filing → |
| NUVL | SELL | 2026-03-16 | $3.4M | — | Filing → |
| NUVL | SELL | 2026-01-07 | $502K | — | Filing → |
| NUVL | SELL | 2025-10-17 | $2.6M | — | Filing → |